RAPT Therapeutics, Inc. Operating Expenses
RAPT Therapeutics, Inc. reported Operating Expenses of $19.37 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2025-11-06
- RAPT Therapeutics, Inc. operating expenses for the quarter ending 2025-09-30 was $19.37M, a 2.11% decline year-over-year.
- RAPT Therapeutics, Inc. operating expenses for the quarter ending 2025-06-30 was $19.54M, a 33.40% decline year-over-year.
- RAPT Therapeutics, Inc. operating expenses for the quarter ending 2025-03-31 was $19.27M, a 40.76% decline year-over-year.
- RAPT Therapeutics, Inc. operating expenses for the quarter ending 2024-12-31 was $54.47M, a 63.97% increase year-over-year.
- RAPT Therapeutics, Inc. operating expenses for fiscal 2024 was $136.10M, a 7.11% increase from fiscal 2023.
- RAPT Therapeutics, Inc. operating expenses for fiscal 2023 was $127.06M, a 45.51% increase from fiscal 2022.
- RAPT Therapeutics, Inc. operating expenses for fiscal 2022 was $87.32M, a 19.58% increase from fiscal 2021.
- RAPT Therapeutics, Inc. operating expenses for fiscal 2021 was $73.02M, a 25.35% increase from fiscal 2020.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2025-09-30 | $19.37M 10-Q · filed 2025-11-06 | $38.91M derived: sum of 2 quarters · filed 2025-11-06 | $58.17M 10-Q · filed 2025-11-06 | $112.64M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | $19.54M 10-Q · filed 2025-08-07 | $38.80M 10-Q · filed 2025-08-07 | $93.27M derived: sum of 3 quarters · filed 2025-08-07 | $113.05M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-03-31 | $19.27M 10-Q · filed 2025-05-08 | $73.73M derived: sum of 2 quarters · filed 2025-05-08 | $93.52M derived: sum of 3 quarters · filed 2025-11-06 | $122.85M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-12-31 | $54.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $74.25M derived: sum of 2 quarters · filed 2025-11-06 | $103.58M derived: sum of 3 quarters · filed 2025-11-06 | $136.10M 10-K · filed 2025-03-06 |
| 2024-09-30 | $19.79M 10-Q · filed 2025-11-06 | $49.12M derived: sum of 2 quarters · filed 2025-11-06 | $81.64M 10-Q · filed 2025-11-06 | $114.85M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $29.33M 10-Q · filed 2025-08-07 | $61.85M 10-Q · filed 2025-08-07 | $95.06M derived: sum of 3 quarters · filed 2025-08-07 | $128.98M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $32.52M 10-Q · filed 2025-05-08 | $65.73M derived: sum of 2 quarters · filed 2025-05-08 | $99.65M derived: sum of 3 quarters · filed 2025-05-08 | $128.02M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $33.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $67.14M derived: sum of 2 quarters · filed 2025-03-06 | $95.50M derived: sum of 3 quarters · filed 2025-03-06 | $127.06M 10-K · filed 2025-03-06 |
| 2023-09-30 | $33.92M 10-Q · filed 2024-11-12 | $62.28M derived: sum of 2 quarters · filed 2024-11-12 | $93.84M 10-Q · filed 2024-11-12 | $118.28M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $28.36M 10-Q · filed 2024-08-08 | $59.93M 10-Q · filed 2024-08-08 | $84.36M derived: sum of 3 quarters · filed 2024-08-08 | $106.03M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $31.56M 10-Q · filed 2024-05-09 | $55.99M derived: sum of 2 quarters · filed 2024-05-09 | $77.67M derived: sum of 3 quarters · filed 2024-05-09 | $97.47M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $24.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $46.11M derived: sum of 2 quarters · filed 2024-03-07 | $65.90M derived: sum of 3 quarters · filed 2024-03-07 | $87.32M 10-K · filed 2024-03-07 |
| 2022-09-30 | $21.68M 10-Q · filed 2023-11-13 | $41.47M derived: sum of 2 quarters · filed 2023-11-13 | $62.89M 10-Q · filed 2023-11-13 | $81.68M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $19.80M 10-Q · filed 2023-08-11 | $41.21M 10-Q · filed 2023-08-11 | $60.00M derived: sum of 3 quarters · filed 2023-08-11 | $79.50M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $21.42M 10-Q · filed 2023-05-11 | $40.21M derived: sum of 2 quarters · filed 2023-05-11 | $59.71M derived: sum of 3 quarters · filed 2023-05-11 | $76.66M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $18.79M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $38.29M derived: sum of 2 quarters · filed 2023-03-14 | $55.24M derived: sum of 3 quarters · filed 2023-03-14 | $73.02M 10-K · filed 2023-03-14 |
| 2021-09-30 | $19.50M 10-Q · filed 2022-11-10 | $36.45M derived: sum of 2 quarters · filed 2022-11-10 | $54.23M 10-Q · filed 2022-11-10 | $68.62M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $16.95M 10-Q · filed 2022-08-11 | $34.73M 10-Q · filed 2022-08-11 | $49.12M derived: sum of 3 quarters · filed 2022-08-11 | $65.23M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $17.78M 10-Q · filed 2022-05-11 | $32.17M derived: sum of 2 quarters · filed 2022-05-11 | $48.28M derived: sum of 3 quarters · filed 2022-05-11 | $62.07M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $14.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $30.50M derived: sum of 2 quarters · filed 2022-03-10 | $44.28M derived: sum of 3 quarters · filed 2022-03-10 | $58.26M 10-K · filed 2022-03-10 |
| 2020-09-30 | $16.11M 10-Q · filed 2021-11-10 | $29.90M derived: sum of 2 quarters · filed 2021-11-10 | $43.87M 10-Q · filed 2021-11-10 | $56.68M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $13.79M 10-Q · filed 2021-08-11 | $27.76M 10-Q · filed 2021-08-11 | $40.58M derived: sum of 3 quarters · filed 2021-08-11 | $50.89M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $13.97M 10-Q · filed 2021-05-11 | $26.79M derived: sum of 2 quarters · filed 2021-05-11 | $37.10M derived: sum of 3 quarters · filed 2021-05-11 | $48.06M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $12.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $23.13M derived: sum of 2 quarters · filed 2021-03-11 | $34.09M derived: sum of 3 quarters · filed 2021-03-11 | $43.63M 10-K · filed 2021-03-11 |
| 2019-09-30 | $10.31M 10-Q · filed 2020-11-16 | $21.27M derived: sum of 2 quarters · filed 2020-11-16 | $30.81M 10-Q · filed 2020-11-16 | $40.49M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $10.96M 10-Q · filed 2020-08-13 | $20.50M 10-Q · filed 2020-08-13 | $30.17M derived: sum of 3 quarters · filed 2020-08-13 | $40.72M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $9.54M 10-Q · filed 2020-05-14 | $19.21M derived: sum of 2 quarters · filed 2020-05-14 | $29.76M derived: sum of 3 quarters · filed 2020-05-14 | |
| 2018-12-31 | $9.67M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $20.22M derived: sum of 2 quarters · filed 2020-03-30 | $36.95M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $10.54M 10-Q · filed 2019-12-11 | $27.28M 10-Q · filed 2019-12-11 |